Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel.
Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel; The Department of Obstetrics and Gynecology, the Chaim Sheba Medical Center, Ramat-Gan, Israel.
Eur J Obstet Gynecol Reprod Biol. 2023 Jun;285:12-16. doi: 10.1016/j.ejogrb.2023.03.028. Epub 2023 Mar 24.
Evaluation of preeclampsia (PE) incidence among participants undergoing in vitro fertilization (IVF) after various cycles of sperm donation (SD) via intrauterine inseminations (IUI) or IVF.
A retrospective case-control study was conducted at a single tertiary medical center between 2011 and 2019 which included participants who conceived via IVF using SD from a single sperm bank and had a successful singleton birth at Sheba Medical Center. The study cohort was divided into two groups: Group 1 (participants who conceived via IVF after 0-1 cycles of IUI or IVF from the same sperm donor) and Group 2 (participants who conceived via IVF after 2 or more cycles of IUI or IVF from the same sperm donor). Baseline characteristics and pregnancy outcomes between the two groups were compared. In addition, a comparison between the study groups and a control of participants of the same age who conceived spontaneously and had a singleton birth at Sheba Medical Center during the same period with a record of up to two previous deliveries was done.
A total of 228 participants conceived through IVF from SD and met the inclusion criteria. Of these, 110 were defined as Group 1 and 118 as Group 2. The participants showed no differences in their age, gravidity and parity, chronic medical conditions, or history of pregnancy complications. Preeclampsia was positively associated with Group 1 (9 [8.2%] vs. 2 [1.7%], P = 0.022). PE was observed to be more prevalent in Group 1 (P < 0.001) when compared to a control group of 45,278 participants who conceived spontaneously. No significant differences were observed in comparing Group 2 with the same control group.
The incidence of PE was higher among participants who were exposed to 0-1 IUI or IVF cycles than in those who were exposed to 2 or more cycles of IUI or IVF from the same sperm donor. On comparing both groups with a control group, the incidence of PE was higher in participants who were exposed to 0-1 cycles, while there was no difference in participants exposed to 2 or more cycles.
If there is a statistically significant increase in the incidence of PE when conception occurred following fewer sperm exposures, then there may be a correlation between these two. The reason for this is not entirely clear, but based on former literature, we hypothesize it may be related to the fact that repeated exposures to paternal antigens may alter the maternal immune response causing a better adaptation to the semi-allogenic nature of the fetus, its paternal half.
评估接受供精者精子通过宫腔内人工授精(IUI)或体外受精(IVF)进行不同周期治疗后行 IVF 助孕的患者子痫前期(PE)的发生率。
本研究为单中心回顾性病例对照研究,纳入了 2011 年至 2019 年在谢巴医疗中心接受供精者精子通过单一家精子库行 IVF 助孕并成功分娩单胎活婴的患者。该研究队列分为两组:第 1 组(接受供精者精子通过 IUI 或 IVF 治疗 0-1 个周期)和第 2 组(接受供精者精子通过 IUI 或 IVF 治疗 2 个或更多周期)。比较两组患者的基本特征和妊娠结局。此外,还比较了研究组与同期在谢巴医疗中心接受自然受孕并分娩单胎活婴的年龄相同的患者(记录有 1-2 次既往分娩史)的记录。
共 228 名接受供精者精子行 IVF 助孕的患者符合纳入标准。其中 110 名患者被定义为第 1 组,118 名患者被定义为第 2 组。两组患者的年龄、孕次和产次、慢性疾病史或妊娠并发症史无差异。PE 与第 1 组显著相关(9[8.2%]例 vs. 2[1.7%]例,P=0.022)。与 45278 名接受自然受孕的患者相比,第 1 组的 PE 发生率更高(P<0.001)。与同期接受自然受孕的患者相比,第 2 组与对照组比较无显著差异。
与接受 2 个或更多 IUI 或 IVF 周期治疗的患者相比,接受 0-1 个 IUI 或 IVF 周期治疗的患者发生 PE 的风险更高。与对照组相比,接受 0-1 个周期治疗的患者 PE 发生率更高,而接受 2 个或更多周期治疗的患者 PE 发生率无差异。
如果受孕后发生 PE 的风险在精液暴露次数较少时显著增加,则两者之间可能存在相关性。其原因尚不完全清楚,但根据以往的文献,我们假设这可能与反复暴露于父系抗原会改变母体免疫反应,从而更好地适应胎儿的半同种异体性质(其父系)有关。